Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position (Q72432520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

G. P. McNicol

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6106840

6 August 2023

language of work or name

English

0 references

publication date

1 October 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

4 October 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6106840

full work available at URL

6 August 2023

https://api.elsevier.com/content/article/PII:S0140673680919509?httpAccept=text/xml

1 reference

10.1016/S0140-6736(80)91950-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(80)91950-9

https://api.elsevier.com/content/article/PII:S0140673680919509?httpAccept=text/plain

6 August 2023

1 reference

10.1016/S0140-6736(80)91950-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(80)91950-9

6 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

8197

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

736-738

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

Aspirin: A paradoxical effect on bleeding-time

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Regular aspirin use and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Aspirin and secondary mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Sulfinpyrazone in the prevention of sudden death after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Secondary prevention of myocardial infarction--the present state of the ART

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

FDA says no to anturane

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2991950-9

7 January 2021

10.1016/S0140-6736(80)91950-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6106840%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference